GuidanceMHRA
Reporting adverse incidents: neurostimulators
For manufacturers reporting adverse incidents with neurostimulators under the vigilance system.
First published: May 31, 2013Last updated: Jan 15, 2025Changes: 3
Latest change: Updated to reflect the laying of The Medical Devices (Post-market Surveillance requirements) (Amendment) Regulations 2024.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.